Setback For ACOR In Ampyra Suit, EARS Put On Notice, STDY On Steady Rise

Shares of SteadyMed Ltd. (STDY) rose more than 46% on Friday, following a favorable ruling in the Inter Partes Review (IPR) proceeding against United Therapeutics covering patent No. 8,497,393.

from RTT - Biotech http://ift.tt/2n2XDB2
via IFTTT